ALLO-329

ALLO-329 · Allogene Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALLO-329, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease [Phase 1]

See pricing